SARAH BEATTY: Open Payments
NPI 1396237566 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 19 payments from 11 companies in 2025. Trend: 2023 $23 · 2024 $467 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $91 |
| Neurocrine BioSciences, Inc. | 3 | $62 |
| Almatica Pharma LLC | 3 | $46 |
| ABBVIE INC. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Neos Therapeutics, LP | 1 | $28 |
| Alkermes, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $19 |
Products named: SPRAVATO, INGREZZA, LOREEV XR, VRAYLAR, HETLIOZ, Adzenys XR-ODT, ARISTADA, CAPLYTA.
Industry payments across NC — which companies pay providers there.
